Ulrike Bacher

Nov 29, 2024 | mdpi.com | Katja Seipel |Lynn Benninger |Ulrike Bacher |Thomas Pabst

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Mar 29, 2024 | mdpi.com | Katja Seipel |Harpreet Mandhair |Ulrike Bacher |Thomas Pabst

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Nov 20, 2023 | onlinelibrary.wiley.com | Ulrike Bacher |Evgenii Shumilov |Thomas Pabst

Currently, our understanding is limited regarding the relationship between anti-SARS-CoV-2 antibody levels post-COVID-19 vaccination and their protective value against the B.1.1.529 (Omicron) variant of SARS-CoV-2. In addition, the benefit of mRNA-based COVID-19 vaccines against the Omicron variant in patients with haematological malignancies remains to be clarified. In their paper the authors1 present the results of a prospective study from Lithuania.

Aug 23, 2023 | mdpi.com | Katja Seipel |Ulrike Bacher |Thomas Pabst |Scarlett Kohler

Open AccessArticleby 1,*, 1, 2 and 3 1Department for Biomedical Research, University of Bern, 3008 Bern, Switzerland2Department of Hematology, University Hospital Bern, 3010 Bern, Switzerland3Department of Medical Oncology, University Hospital Bern, 3010 Bern, Switzerland*Author to whom correspondence should be addressed. Curr. Issues Mol. Biol.

Jul 30, 2023 | onlinelibrary.wiley.com | Ulrike Bacher |Evgenii Shumilov |Thomas Pabst |Dell'Eva M

Ulrike Bacher and Evgenii Shumilov contributed equally and should both be considered as first authors. Commentary on: Pinder et al. Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccination. Br J Haematol 2023 (Online ahead of print). doi: 10.1111/bjh.18962.